Tirzepatide, a novel medication, is sparking significant excitement in the medical community as a potential treatment for both diabetes, type 2 and body composition . This dual-action drug works by targeting two different receptors, GLP-1 and GIP, leading to improved blood sugar levels and notable weight reduction in testing. While early results ar